Newleos Therapeutics’ $93.5 Million Series A Financing Round

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Newleos Therapeutics in the transaction.Newleos Therapeutics, a clinical stage neuroscience company co-founded by Longwood Fund and seasoned leaders…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here